Company · CIK 0000318154 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
AMGEN INC · AMGN
Insider activity reported against this company. All insider holders · Files at: KZR, UNIS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 MForm 4 → | Aug 13, 7:05 pm EDT | Rachna KhoslaSVP, Business Development | 1,252 | $162.60 | $203,575 | 7,656 | — | |
| Aug 11, 2026 SForm 4 → | Aug 13, 7:05 pm EDT | Rachna KhoslaSVP, Business Development | 3,252 | $414.05 | $1,346,499 | 6,404 | −33.7% | |
| Aug 7, 2026 AForm 4 → | Aug 12, 8:04 pm EDT | Matthew C. BuschVP, Finance & CAO | 730 | — | — | 5,080 | — | late |
| Aug 7, 2026 AForm 4 → | Aug 10, 8:24 pm EDT | Omar IshrakDirector | 85 | — | — | 7,486 | — | |
| Aug 7, 2026 AForm 4 → | Aug 10, 8:22 pm EDT | Charles M HolleyDirector | 103 | — | — | 12,990 | — | |
| Aug 7, 2026 AForm 4 → | Aug 10, 8:20 pm EDT | Michael V DrakeDirector | 64 | — | — | 5,876 | — | |
| Aug 6, 2026 SForm 4 → | Aug 7, 6:47 pm EDT | Derek MillerSVP, Human Resources | 3,890 | $402.54 | $1,565,898 | 12,462 | −23.8% | |
| Aug 6, 2026 MForm 4 → | Aug 7, 6:47 pm EDT | Derek MillerSVP, Human Resources | 3,890 | $169.56 | $659,574 | 14,283 | — | |
| Aug 6, 2026 SForm 4 → | Aug 7, 6:45 pm EDT | Nancy A. GrygielSVP & CCO | 2,970 | $402.16 | $1,194,415 | 7,340 | −28.8% | |
| Aug 6, 2026 MForm 4 → | Aug 7, 6:45 pm EDT | Nancy A. GrygielSVP & CCO | 2,970 | $177.41 | $526,906 | 8,340 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 MForm 4 → | Aug 13, 7:05 pm EDT | Rachna KhoslaSVP, Business Development | 1,252 | — | — | 0 | — | |
| Aug 6, 2026 MForm 4 → | Aug 7, 6:47 pm EDT | Derek MillerSVP, Human Resources | 3,890 | — | — | 0 | — | |
| Aug 6, 2026 MForm 4 → | Aug 7, 6:45 pm EDT | Nancy A. GrygielSVP & CCO | 2,970 | — | — | 2,948 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.